RecruitingPhase 2 / Phase 3NCT06712316
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)
Sponsor: BioNTech SE
Marietta, GA · +52 more sites
Lung Cancer clinical trials in Marietta, GA
5 recruiting lung cancer studies with a site in Marietta, GA.
RecruitingPhase 3NCT06646276
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
Sponsor: Bristol-Myers Squibb
Marietta, GA · +19 more sites
RecruitingPhase 3NCT07361497
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Sponsor: Bristol-Myers Squibb
Marietta, GA · +37 more sites
RecruitingPhase 3NCT07361510
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Sponsor: Bristol-Myers Squibb
Athens, GA · Augusta, GA · Marietta, GA · +38 more sites
RecruitingNot applicableNCT07711691
Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+)
Sponsor: University of California, Irvine
Alpharetta, GA · Atlanta, GA · +54 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.